Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (387)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
52
2026
3013
3.280
 Why?
HIV-1
28
2026
892
2.960
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
38
2.260
 Why?
HIV Antibodies
14
2026
66
2.260
 Why?
Respiratory Syncytial Virus Infections
6
2022
135
2.070
 Why?
Respiratory Syncytial Virus, Human
6
2022
82
2.060
 Why?
Infectious Disease Transmission, Vertical
18
2025
187
2.040
 Why?
Anti-Retroviral Agents
13
2026
242
1.880
 Why?
Anti-HIV Agents
15
2026
861
1.790
 Why?
Viral Proteins
3
2020
370
1.490
 Why?
Antibodies, Neutralizing
10
2026
328
1.140
 Why?
Antibodies, Viral
8
2022
666
1.080
 Why?
Colonography, Computed Tomographic
3
2024
8
0.940
 Why?
Pregnancy Complications, Infectious
9
2026
420
0.890
 Why?
Antibodies, Monoclonal
7
2026
1474
0.870
 Why?
HIV Protease Inhibitors
3
2026
69
0.840
 Why?
AIDS Vaccines
8
2018
54
0.830
 Why?
Pre-Exposure Prophylaxis
1
2025
241
0.760
 Why?
Gene Deletion
2
2020
394
0.700
 Why?
Breast Feeding
4
2025
444
0.620
 Why?
Atazanavir Sulfate
2
2017
42
0.610
 Why?
Infant, Newborn
25
2026
6366
0.600
 Why?
Ritonavir
2
2017
72
0.600
 Why?
HIV Envelope Protein gp120
6
2017
61
0.560
 Why?
Vaccines, Attenuated
6
2022
130
0.560
 Why?
Vaccination
6
2020
1484
0.540
 Why?
Incidental Findings
1
2018
81
0.530
 Why?
Infant
33
2026
9981
0.530
 Why?
Nelfinavir
1
2016
8
0.490
 Why?
Telemedicine
1
2025
926
0.490
 Why?
Radiation Dosage
1
2018
195
0.490
 Why?
Lopinavir
1
2016
28
0.480
 Why?
Syncope
1
2016
58
0.480
 Why?
Bradycardia
1
2016
52
0.480
 Why?
Patient Dropouts
1
2016
65
0.470
 Why?
Lyme Disease
1
2016
57
0.460
 Why?
Health Resources
1
2016
129
0.440
 Why?
Infant, Newborn, Diseases
1
2016
113
0.430
 Why?
HIV
5
2014
249
0.400
 Why?
Humans
78
2026
143560
0.390
 Why?
Patient Compliance
2
2018
617
0.380
 Why?
Child
38
2026
22725
0.380
 Why?
Female
52
2026
77252
0.380
 Why?
Immunogenicity, Vaccine
4
2021
34
0.370
 Why?
Viral Load
11
2026
514
0.370
 Why?
Referral and Consultation
1
2018
828
0.360
 Why?
T-Lymphocytes, Cytotoxic
4
2005
174
0.350
 Why?
Male
43
2026
71501
0.340
 Why?
CD4-Positive T-Lymphocytes
2
2017
1130
0.340
 Why?
Virus Replication
4
2020
544
0.330
 Why?
Adolescent
28
2025
22482
0.330
 Why?
Lymphocyte Activation
5
2017
1143
0.300
 Why?
Young Adult
14
2026
13972
0.280
 Why?
HIV Seropositivity
2
2023
119
0.270
 Why?
DNA, Viral
3
2026
366
0.270
 Why?
Bone Density
2
2025
503
0.260
 Why?
Double-Blind Method
3
2020
2017
0.250
 Why?
RNA, Viral
8
2023
704
0.240
 Why?
Antibodies, Bacterial
2
2018
146
0.240
 Why?
Dyslipidemias
2
2017
179
0.230
 Why?
Antiretroviral Therapy, Highly Active
6
2017
278
0.230
 Why?
Bone Development
1
2025
54
0.230
 Why?
Prenatal Exposure Delayed Effects
2
2026
681
0.220
 Why?
Immunoenzyme Techniques
1
2005
206
0.220
 Why?
Puberty
1
2026
158
0.220
 Why?
Pregnancy
12
2026
7153
0.210
 Why?
Immunoglobulin G
3
2022
898
0.210
 Why?
Diverticulum
1
2024
12
0.210
 Why?
Viremia
3
2011
156
0.210
 Why?
Gene Products, gag
2
1994
38
0.210
 Why?
Mammography
1
2025
161
0.200
 Why?
Child, Preschool
21
2022
11737
0.200
 Why?
Squalene
3
2017
8
0.190
 Why?
Complementarity Determining Regions
1
2002
52
0.190
 Why?
Prospective Studies
5
2025
7900
0.180
 Why?
Drug Resistance, Viral
2
2016
122
0.180
 Why?
CD4 Lymphocyte Count
4
2017
274
0.180
 Why?
Half-Life
1
2021
147
0.180
 Why?
Growth Differentiation Factor 15
1
2021
42
0.180
 Why?
Feasibility Studies
1
2025
1051
0.170
 Why?
Mitochondrial Diseases
1
2021
94
0.170
 Why?
Immunization Schedule
2
2018
202
0.170
 Why?
Colorado
4
2025
4658
0.170
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
335
0.160
 Why?
Drug Therapy, Combination
4
2017
1058
0.160
 Why?
RNA, Small Untranslated
1
2020
13
0.160
 Why?
Fibroblast Growth Factors
1
2021
186
0.160
 Why?
T-Lymphocytes
2
2009
2026
0.160
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
 Why?
Pilot Projects
1
2025
1838
0.160
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
190
0.150
 Why?
Cytokines
2
2021
2097
0.150
 Why?
Body Temperature
1
2020
224
0.150
 Why?
Point Mutation
1
2020
243
0.150
 Why?
Haemophilus Vaccines
2
2018
30
0.140
 Why?
Immunocompromised Host
2
2000
206
0.140
 Why?
Insulin Resistance
3
2019
1234
0.140
 Why?
Immunologic Memory
2
2021
365
0.140
 Why?
Darunavir
1
2017
20
0.140
 Why?
Interleukin-12
1
1998
124
0.140
 Why?
Metabolic Syndrome
1
2021
354
0.130
 Why?
CD8-Positive T-Lymphocytes
2
2011
928
0.130
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
367
0.130
 Why?
Therapeutic Equipoise
1
2017
2
0.130
 Why?
Dose-Response Relationship, Drug
1
2021
2056
0.130
 Why?
Interferon-gamma
5
2012
791
0.130
 Why?
Antibody Formation
1
2018
297
0.130
 Why?
Lymphopoiesis
1
2017
27
0.130
 Why?
Immunoglobulin A
2
2017
218
0.130
 Why?
Uganda
1
2017
89
0.130
 Why?
Receptors, CCR5
1
2017
61
0.130
 Why?
CD4-CD8 Ratio
1
2016
24
0.130
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
 Why?
High-Throughput Screening Assays
1
2018
161
0.120
 Why?
Adoption
1
2016
32
0.120
 Why?
Adult
16
2026
40012
0.120
 Why?
Virus Latency
1
2016
80
0.120
 Why?
Mothers
3
2017
783
0.120
 Why?
Cohort Studies
8
2025
5891
0.120
 Why?
Continuity of Patient Care
1
2018
284
0.110
 Why?
Early Diagnosis
1
2016
247
0.110
 Why?
Chickenpox Vaccine
1
2015
74
0.110
 Why?
Zimbabwe
2
2025
63
0.110
 Why?
Disease Susceptibility
1
2017
354
0.110
 Why?
Gene Products, env
1
1994
6
0.110
 Why?
Body Height
2
2017
208
0.110
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Chickenpox
1
2015
81
0.110
 Why?
Bacterial Capsules
1
2014
33
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
233
0.110
 Why?
Cote d'Ivoire
2
2025
8
0.110
 Why?
Parotitis
1
2014
6
0.110
 Why?
South Africa
2
2025
208
0.110
 Why?
Vaccines, Synthetic
4
2005
139
0.110
 Why?
Developing Countries
1
2016
308
0.100
 Why?
Intestines
1
2017
356
0.100
 Why?
Cytotoxicity, Immunologic
3
2002
222
0.100
 Why?
Puberty, Delayed
1
2013
9
0.100
 Why?
Leukocytes, Mononuclear
4
2013
589
0.100
 Why?
RNA-Directed DNA Polymerase
1
1993
35
0.100
 Why?
Mycobacterium chelonae
1
1993
9
0.100
 Why?
Vaccines
1
2018
410
0.100
 Why?
Patient Selection
1
2017
691
0.100
 Why?
Retrospective Studies
8
2023
16740
0.090
 Why?
Lipids
1
2017
704
0.090
 Why?
Lamivudine
3
2023
64
0.090
 Why?
Colorectal Neoplasms
1
2020
833
0.090
 Why?
Breast Neoplasms
1
2025
2318
0.090
 Why?
Cell Movement
1
2017
973
0.090
 Why?
Mitochondria
2
2021
988
0.090
 Why?
Cardiovascular Diseases
2
2016
2113
0.090
 Why?
STAT1 Transcription Factor
1
2012
71
0.090
 Why?
Clinical Trials as Topic
1
2017
1043
0.090
 Why?
Pediatric Obesity
1
2019
634
0.090
 Why?
Child Development
1
2017
506
0.090
 Why?
Body Fat Distribution
1
2011
47
0.090
 Why?
Polysorbates
3
2017
41
0.090
 Why?
Body Weight
2
2017
1003
0.090
 Why?
Mycobacterium avium Complex
1
2012
88
0.090
 Why?
Epitopes
2
2022
489
0.090
 Why?
Cost-Benefit Analysis
2
2025
621
0.080
 Why?
Research Design
1
2017
1123
0.080
 Why?
United States
9
2023
15554
0.080
 Why?
Biomedical Research
1
2017
699
0.080
 Why?
Interleukin-2
2
2003
451
0.080
 Why?
Respiratory Tract Infections
1
2014
389
0.080
 Why?
Exercise
1
2021
2152
0.070
 Why?
Freezing
1
2009
88
0.070
 Why?
Absorptiometry, Photon
2
2025
272
0.070
 Why?
Blood
1
2009
110
0.070
 Why?
Algorithms
1
2016
1813
0.070
 Why?
Phenotype
1
2017
3211
0.070
 Why?
Staff Development
1
2009
60
0.070
 Why?
Age Factors
4
2019
3328
0.070
 Why?
T-Lymphocyte Subsets
2
2002
422
0.070
 Why?
Lymphocyte Subsets
2
2009
87
0.070
 Why?
Biomarkers
4
2021
4241
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
856
0.070
 Why?
Specimen Handling
1
2009
181
0.070
 Why?
Longitudinal Studies
3
2025
3006
0.070
 Why?
Enterovirus A, Human
1
2007
13
0.070
 Why?
Faculty
1
2009
153
0.070
 Why?
Withholding Treatment
1
2008
79
0.070
 Why?
Adipose Tissue
1
2011
654
0.060
 Why?
Central Nervous System Viral Diseases
1
2007
79
0.060
 Why?
Polymerase Chain Reaction
4
2011
1062
0.060
 Why?
Flow Cytometry
3
2009
1192
0.060
 Why?
Academic Medical Centers
1
2009
535
0.060
 Why?
False Negative Reactions
1
2025
61
0.060
 Why?
Isoantigens
1
1984
17
0.060
 Why?
Enterovirus Infections
1
2007
174
0.050
 Why?
C-Reactive Protein
2
2021
418
0.050
 Why?
Cell Line
3
2012
2897
0.050
 Why?
Medical Audit
1
2025
77
0.050
 Why?
Immunity, Cellular
1
2006
267
0.050
 Why?
Linear Models
2
2020
858
0.050
 Why?
Disease Outbreaks
1
2007
430
0.050
 Why?
Follow-Up Studies
3
2021
5308
0.050
 Why?
Confusion
1
2024
31
0.050
 Why?
Sequence Analysis, DNA
2
2007
823
0.050
 Why?
Comorbidity
2
2021
1678
0.050
 Why?
Thymus Gland
1
1984
319
0.050
 Why?
Tablets
1
2023
42
0.050
 Why?
Constriction, Pathologic
1
2024
246
0.050
 Why?
Regression Analysis
2
2021
1013
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
 Why?
Risk Factors
4
2021
10644
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
 Why?
Immunophenotyping
2
1994
326
0.050
 Why?
Zidovudine
2
2015
77
0.050
 Why?
Clone Cells
1
2002
270
0.050
 Why?
Dose-Response Relationship, Immunologic
1
2001
77
0.040
 Why?
Cough
1
2022
133
0.040
 Why?
Triazoles
1
2023
168
0.040
 Why?
Emtricitabine
1
2023
205
0.040
 Why?
Vaccines, Subunit
1
2001
52
0.040
 Why?
Pyridones
1
2023
198
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Tenofovir
1
2023
292
0.040
 Why?
Public Health Surveillance
1
2021
83
0.040
 Why?
Lung
1
2014
4101
0.040
 Why?
Africa
1
2020
114
0.040
 Why?
Computer Simulation
1
2005
1028
0.040
 Why?
Adjuvants, Immunologic
2
2017
240
0.040
 Why?
Injections, Subcutaneous
1
2020
165
0.040
 Why?
Diagnostic Tests, Routine
1
2021
110
0.040
 Why?
Symptom Assessment
1
2021
133
0.040
 Why?
Sex Factors
2
2019
2092
0.040
 Why?
Cross-Sectional Studies
3
2021
5743
0.040
 Why?
HIV Seronegativity
1
2019
30
0.040
 Why?
HLA-D Antigens
1
1999
30
0.040
 Why?
Risk
1
2021
906
0.040
 Why?
Cytomegalovirus Infections
1
2000
199
0.040
 Why?
Case-Control Studies
2
2019
3625
0.040
 Why?
Cholesterol, HDL
1
2019
197
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
51
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
37
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
27
0.040
 Why?
Prevalence
2
2016
2830
0.040
 Why?
Vaccines, Combined
1
2018
49
0.040
 Why?
Hospitals
1
2023
691
0.040
 Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
 Why?
Amino Acid Sequence
1
2002
2165
0.040
 Why?
Odds Ratio
1
2021
1060
0.030
 Why?
Hepatitis B Vaccines
1
2018
47
0.030
 Why?
Mutation
3
2018
4053
0.030
 Why?
Drug Resistance, Microbial
2
2000
67
0.030
 Why?
Molecular Sequence Data
1
2002
2942
0.030
 Why?
Colon
1
2020
306
0.030
 Why?
Nutrition Surveys
1
2019
282
0.030
 Why?
Case Management
1
2018
66
0.030
 Why?
Antigens, Viral
1
1998
179
0.030
 Why?
Cholesterol
1
2019
404
0.030
 Why?
Cholesterol, LDL
1
2019
363
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
184
0.030
 Why?
Immune Tolerance
1
1999
381
0.030
 Why?
Treatment Adherence and Compliance
1
2017
27
0.030
 Why?
Triglycerides
1
2019
517
0.030
 Why?
Reproducibility of Results
1
2005
3380
0.030
 Why?
Disease Management
1
2021
646
0.030
 Why?
Lymphocyte Count
2
2009
167
0.030
 Why?
Cell Division
1
1998
806
0.030
 Why?
Uncertainty
1
2017
140
0.030
 Why?
Treatment Failure
1
2017
357
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Multicenter Studies as Topic
1
2017
389
0.030
 Why?
Seroepidemiologic Studies
1
2015
171
0.030
 Why?
Patient Outcome Assessment
1
2016
132
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Malnutrition
1
2016
85
0.030
 Why?
Time-to-Treatment
1
2017
228
0.030
 Why?
Coinfection
1
2016
133
0.030
 Why?
Maternal Exposure
1
2017
214
0.030
 Why?
Antiviral Agents
1
2000
764
0.030
 Why?
Vaccines, Conjugate
1
2014
63
0.030
 Why?
Neutropenia
1
2015
152
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1672
0.030
 Why?
Counseling
1
2018
398
0.030
 Why?
Treatment Outcome
2
2021
11365
0.030
 Why?
Cells, Cultured
2
2008
4182
0.030
 Why?
Sexual and Gender Minorities
1
2018
241
0.030
 Why?
Global Health
1
2017
387
0.030
 Why?
Anemia
1
2015
177
0.030
 Why?
Maternal-Fetal Exchange
1
2014
170
0.030
 Why?
Electron Transport Complex IV
1
2013
61
0.030
 Why?
Electron Transport Complex I
1
2013
42
0.020
 Why?
Tuberculosis, Cutaneous
1
1993
3
0.020
 Why?
Thrombocytopenia
1
2015
209
0.020
 Why?
HIV Reverse Transcriptase
1
1993
31
0.020
 Why?
CD8 Antigens
1
1993
75
0.020
 Why?
Medication Adherence
1
2017
515
0.020
 Why?
Radiography, Thoracic
1
2014
180
0.020
 Why?
Severity of Illness Index
1
2021
2936
0.020
 Why?
CD3 Complex
1
1993
107
0.020
 Why?
Drug Administration Schedule
2
2008
773
0.020
 Why?
Blood Pressure
1
2019
1755
0.020
 Why?
Oxidative Phosphorylation
1
2013
209
0.020
 Why?
Lymphocytes
1
1994
398
0.020
 Why?
DNA, Mitochondrial
1
2013
211
0.020
 Why?
P-Selectin
1
2011
28
0.020
 Why?
E-Selectin
1
2011
61
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
130
0.020
 Why?
Pandemics
1
2020
1668
0.020
 Why?
Chemokine CCL2
1
2011
115
0.020
 Why?
Antigens, CD
1
1994
549
0.020
 Why?
Blood Transfusion
1
1994
401
0.020
 Why?
Hyperlipidemias
1
2011
127
0.020
 Why?
Hospitalization
1
2021
2313
0.020
 Why?
Interferon-alpha
1
2012
197
0.020
 Why?
Cell Proliferation
2
2009
2542
0.020
 Why?
Protein Multimerization
1
2012
205
0.020
 Why?
Fibrinogen
1
2011
179
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
209
0.020
 Why?
Cell Adhesion Molecules
1
2011
180
0.020
 Why?
Healthcare Disparities
1
2017
691
0.020
 Why?
Cross Infection
1
1993
261
0.020
 Why?
Infant, Premature
1
1994
608
0.020
 Why?
Pokeweed Mitogens
1
2009
7
0.020
 Why?
Diagnosis, Differential
1
2014
1504
0.020
 Why?
L-Selectin
1
2009
27
0.020
 Why?
Human Experimentation
1
2009
13
0.020
 Why?
Tetanus
1
2009
27
0.020
 Why?
Leukocyte Common Antigens
1
2009
88
0.020
 Why?
Candida
1
2009
41
0.020
 Why?
Multivariate Analysis
1
2011
1510
0.020
 Why?
Obesity
1
2021
3042
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
31
0.020
 Why?
Interleukin-6
1
2011
781
0.020
 Why?
Phosphorylation
1
2012
1781
0.020
 Why?
Cerebrospinal Fluid
1
2007
91
0.020
 Why?
Data Interpretation, Statistical
1
2009
377
0.020
 Why?
Paralysis
1
2007
70
0.020
 Why?
Multiple Organ Failure
1
2007
127
0.020
 Why?
Pregnancy Outcome
1
2010
464
0.020
 Why?
B-Lymphocytes
1
2012
884
0.020
 Why?
Kinetics
1
2010
1628
0.020
 Why?
Respiratory System
1
2007
156
0.020
 Why?
Genotype
1
2011
1877
0.020
 Why?
Immunoglobulin A, Secretory
1
2005
9
0.010
 Why?
Phosphates
1
1987
178
0.010
 Why?
Cell Survival
1
2009
1136
0.010
 Why?
Muscles
1
1987
331
0.010
 Why?
Encephalitis
1
2007
137
0.010
 Why?
Mucous Membrane
1
2005
127
0.010
 Why?
Gastrointestinal Tract
1
2007
204
0.010
 Why?
Chemistry, Physical
1
1984
37
0.010
 Why?
Antigen-Antibody Reactions
1
1984
50
0.010
 Why?
Chemical Phenomena
1
1984
81
0.010
 Why?
Myasthenia Gravis
1
1984
23
0.010
 Why?
DNA-Binding Proteins
1
2012
1524
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
71
0.010
 Why?
Saliva
1
2005
247
0.010
 Why?
Tissue Distribution
1
1984
330
0.010
 Why?
Epithelium
1
1984
314
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2779
0.010
 Why?
Aging
2
2003
1946
0.010
 Why?
Blood Glucose
1
2013
2316
0.010
 Why?
Body Mass Index
1
2011
2430
0.010
 Why?
Infusions, Intravenous
1
2003
423
0.010
 Why?
Middle Aged
2
2020
35343
0.010
 Why?
Anti-Bacterial Agents
1
1993
1906
0.010
 Why?
Reference Values
1
2003
811
0.010
 Why?
Mice, Inbred BALB C
1
1984
1272
0.010
 Why?
Suspensions
1
2000
29
0.010
 Why?
Capsules
1
2000
41
0.010
 Why?
Urban Population
1
2003
491
0.010
 Why?
Drug Tolerance
1
2000
105
0.010
 Why?
Cytomegalovirus
1
2000
166
0.010
 Why?
Signal Transduction
1
2012
5214
0.010
 Why?
Epithelial Cells
1
1984
1125
0.010
 Why?
Administration, Oral
1
2000
842
0.010
 Why?
Immunization
1
2000
404
0.010
 Why?
Time Factors
1
2008
7032
0.010
 Why?
Recombinant Proteins
1
2000
1369
0.010
 Why?
Macrophages
1
1984
1506
0.010
 Why?
Tail
1
1987
29
0.000
 Why?
Phosphocreatine
1
1987
44
0.000
 Why?
Salamandridae
1
1987
33
0.000
 Why?
Mice
1
1984
18378
0.000
 Why?
Animals
2
1987
38010
0.000
 Why?
Aged
1
1984
25322
0.000
 Why?
Adenosine Triphosphate
1
1987
488
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
623
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (387) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)